1. Lin, Fu-Jun, Yao, Lei, Hu, Xue-Qing, Gale, Daniel P, Ren, Hong-Qi. 2019. First identification of PODXL nonsense mutations in autosomal dominant focal segmental glomerulosclerosis. In Clinical science (London, England : 1979), 133, 9-21. doi:10.1042/CS20180676. https://pubmed.ncbi.nlm.nih.gov/30523047/
2. Sudhaman, Sumedha, Prasad, Kameshwar, Behari, Madhuri, Juyal, Ramesh C, Thelma, B K. 2016. Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism. In Journal of medical genetics, 53, 450-6. doi:10.1136/jmedgenet-2015-103459. https://pubmed.ncbi.nlm.nih.gov/26864383/
3. Ding, Yifeng, Wang, Xiaoqing, Shu, Fei, Chen, Xiaohong, Liu, Qingquan. 2024. PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway. In Journal of molecular histology, 55, 1107-1120. doi:10.1007/s10735-024-10253-x. https://pubmed.ncbi.nlm.nih.gov/39198365/
4. Lewis, Michael W, King, Caitlin M, Wisniewska, Kamila, Phanstiel, Douglas H, Franco, Hector L. . CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression. In Cancer research, 84, 3684-3700. doi:10.1158/0008-5472.CAN-23-3995. https://pubmed.ncbi.nlm.nih.gov/39186674/
5. Zhang, Jing, Zhu, Zhonglin, Wu, Huijing, Qiu, Zhengjun, Huang, Chen. 2018. PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer. In Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 22, 48-59. doi:10.1007/s10120-018-0833-y. https://pubmed.ncbi.nlm.nih.gov/29748877/